Wegovy (semaglutide) injection

Wegovy is a prescription medication used for chronic weight management. It contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate appetite. The product shown in the image is a 'Demonstration Pen,' which is used by healthcare providers or patients for training purposes to practice the injection technique without actual medication (it contains a test medium rather than the active drug).

The brand was developed and is owned by Novo Nordisk, a global leader in diabetes and obesity care. While the company is headquartered in Denmark, where much of its high-tech manufacturing takes place, the massive demand for Wegovy has led to expanded production facilities in countries like France and the US to maintain global supply. Novo Nordisk continues to be the ultimate owner and primary manufacturer of the brand.